Necchi, A., Guerrero-Ramos, F., Crispen, P. L., Herrera-Imbroda, B., Garje, R., Szabados, B., Peyton, C. C., Pradere, B., Ku, J. H., Shore, N., Bögemann, M., Preston, M. A., Xylinas, E., Llano, C. S. D., Gong, C., Hasan, M., Urtishak, K., Battaglia, S., Stitou, H., Bhanvadia, S., Sweiti, H., Psutka, S. P. (2026). Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02382